PIAS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.536200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.327800E-01
Normal-vs-Stage2
9.196600E-01
Normal-vs-Stage3
1.197150E-01
Normal-vs-Stage4
5.472000E-01
Stage1-vs-Stage2
8.171800E-01
Stage1-vs-Stage3
9.663300E-03
Stage1-vs-Stage4
5.433200E-01
Stage2-vs-Stage3
7.431800E-02
Stage2-vs-Stage4
4.491400E-01
Stage3-vs-Stage4
4.416300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.739000E-01
Normal-vs-AfricanAmerican
9.288200E-01
Normal-vs-Asian
9.338600E-01
Caucasian-vs-AfricanAmerican
9.171800E-01
Caucasian-vs-Asian
7.691800E-01
AfricanAmerican-vs-Asian
8.389200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.847600E-01
Normal-vs-Female
9.455400E-01
Male-vs-Female
8.398400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.426800E-01
Normal-vs-Age(41-60Yrs)
6.562600E-01
Normal-vs-Age(61-80Yrs)
9.003600E-01
Normal-vs-Age(81-100Yrs)
3.475600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.911000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.341400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.900500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.442200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.179600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.166400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.437200E-01
Normal-vs-Daily Drinker
6.484400E-01
Normal-vs-Weekly Drinker
9.177600E-01
Normal-vs-Occasional Drinker
9.304800E-01
Normal-vs-Social Drinker
8.434600E-01
Non Drinker-vs-Daily Drinker
6.703400E-01
Non Drinker-vs-Weekly Drinker
9.019600E-01
Non Drinker-vs-Occasional Drinker
5.618600E-01
Non Drinker-vs-Social Drinker
4.594800E-01
Daily Drinker-vs-Weekly Drinker
6.449200E-01
Daily Drinker-vs-Occasional Drinker
2.752200E-01
Daily Drinker-vs-Social Drinker
2.362600E-01
Weekly Drinker-vs-Occasional Drinker
7.517800E-01
Weekly Drinker-vs-Social Drinker
6.346000E-01
Occasional Drinker-vs-Social Drinker
7.972000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.377230E-01
Normal-vs-Grade 2
3.517700E-02
Normal-vs-Grade 3
1.382280E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.266410E-01
Grade 1-vs-Grade 3
8.709900E-02
Grade 1-vs-Grade 4
1.377230E-01
Grade 2-vs-Grade 3
7.531200E-01
Grade 2-vs-Grade 4
3.517700E-02
Grade 3-vs-Grade 4
1.382280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.798000E-01
Normal-vs-NonDiabetic
9.705200E-01
Diabetic-vs-NonDiabetic
6.954600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.326600E-01
Normal-vs-NoPancreatitis
9.019800E-01
Pancreatitis-vs-NoPancreatitis
2.632300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.200800E-01
Normal-vs-N1
8.817400E-01
N0-vs-N1
3.871200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.331000E-01
Normal-vs-TP53-NonMutant
8.518600E-01
TP53-Mutant-vs-TP53-NonMutant
5.146800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
